MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

People with type 1 or type 2 diabetes could soon benefit from weekly insulin injections after new research showed they are as effective at controlling blood sugar levels as daily jabs of long-acting ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

“Glucose-responsive – so-called smart – insulins are regarded as the holy grail of insulin as they would come as close to a ...

A new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin in order to reap ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...